Key Financial Results - Consolidated

Quarterly Performance (₹ millions)

  • Revenue from operations: Q2 FY27: ₹20,320.97; Q1 FY27: ₹19,634.83; Q2 FY25: ₹16,584.99
  • Total income: Q2 FY27: ₹20,449.45; Q1 FY27: ₹19,778.06; Q2 FY25: ₹17,166.64
  • Employee benefits expense: Q2 FY27: ₹12,294.40; Q1 FY27: ₹12,275.91; Q2 FY25: ₹10,270.19
  • Profit before exceptional items and tax: Q2 FY27: ₹3,742.21; Q1 FY27: ₹3,025.67; Q2 FY25: ₹3,268.07
  • Exceptional items: Q2 FY27: ₹0; Q1 FY27: ₹150.89; Q2 FY25: ₹0
  • Profit before tax: Q2 FY27: ₹3,742.21; Q1 FY27: ₹2,874.78; Q2 FY25: ₹3,268.07
  • Tax expense: Q2 FY27: ₹900.09; Q1 FY27: ₹706.67; Q2 FY25: ₹759.81
  • Profit for the period: Q2 FY27: ₹2,842.12; Q1 FY27: ₹2,168.11; Q2 FY25: ₹2,508.26
  • Earnings per share (basic): Q2 FY27: ₹0.61; Q1 FY27: ₹0.46; Q2 FY25: ₹0.53

Half-Yearly Performance (₹ millions)

  • Revenue from operations: H1 FY27: ₹39,955.80; H1 FY25: ₹31,974.41; FY26: ₹71,928.51
  • Profit before exceptional items and tax: H1 FY27: ₹6,767.88; H1 FY25: ₹5,371.94; FY26: ₹12,717.22
  • Exceptional items: H1 FY27: ₹150.89; H1 FY25: ₹0; FY26: ₹328.23
  • Profit for the period: H1 FY27: ₹5,010.23; H1 FY25: ₹3,993.85; FY26: ₹9,247.68
  • Earnings per share (basic): H1 FY27: ₹1.07; H1 FY25: ₹0.85; FY26: ₹1.98

Consolidated Balance Sheet (as of September 30, 2026, ₹ millions)

  • Total assets: ₹128,582.74 (March 31, 2026: ₹126,010.78)
  • Property, plant and equipment: ₹4,602.56
  • Right-of-use assets: ₹4,249.63
  • Goodwill: ₹66,085.39
  • Other intangible assets: ₹20,219.13
  • Cash and cash equivalents: ₹5,323.12 (March 31, 2026: ₹3,579.16)
  • Total equity: ₹102,281.01 (March 31, 2026: ₹96,590.97)
  • Equity share capital: ₹46,792.74
  • Borrowings (current): ₹4,254.58 (March 31, 2026: ₹5,775.73)

Key Financial Results - Standalone

Quarterly Performance (₹ millions)

  • Revenue from operations: Q2 FY27: ₹5,751.54; Q1 FY27: ₹5,389.59; Q2 FY25: ₹4,916.77
  • Profit before tax: Q2 FY27: ₹1,299.90; Q1 FY27: ₹1,013.53; Q2 FY25: ₹1,451.76
  • Profit for the period: Q2 FY27: ₹979.44; Q1 FY27: ₹759.76; Q2 FY25: ₹1,108.43
  • Earnings per share (basic): Q2 FY27: ₹0.21; Q1 FY27: ₹0.16; Q2 FY25: ₹0.23

Business Updates and Strategic Developments

Acquisitions

  • CareSeed LLC acquisition: On June 11, 2026, Sagility LLC acquired 100% equity interest in CareSeed LLC for total contractual consideration of USD 30.0 million (₹2,873.38 million), including contingent consideration of up to USD 12.5 million (₹1,197.24 million). Provisional purchase consideration recognized is USD 21.2 million (₹2,032.51 million). Goodwill recognized of USD 15.7 million (₹1,507.58 million).
  • Chirok Health LLC acquisition: On October 21, 2026, through Sagility (US) Holdings Inc., entered definitive agreement to acquire 100% equity shares of Chirok Health LLC for total consideration of USD 32.35 million (₹3,102.44 million), including contingent consideration of up to USD 12.35 million (₹1,184.39 million). Transaction not consummated as of October 22, 2026.

ESOP Trust

  • Company established "Sagility ESOP Trust" on July 7, 2026 for administration of employee stock options. No grants issued as of September 30, 2026.

Exceptional Items

  • Exceptional item of ₹150.89 million recognized in Q1 FY27 due to past service cost from re-measurement of gratuity and leave encashment liabilities following minimum wage increases in Karnataka and Telangana.
  • Similar exceptional item of ₹328.23 million recognized in FY26 due to New Labour Codes implementation.

Dividend Information

  • Final dividend of ₹0.10 per equity share for FY26 approved by shareholders on August 20, 2026 and paid during current quarter.
  • Interim dividend of ₹0.15 per equity share approved on October 22, 2026 with record date October 30, 2026, payable on or before November 21, 2026, resulting in cash outflow of approximately ₹702.20 million.

Operational Highlights

  • Employee count: 51,486 as of September 30, 2026
  • Geographic presence: 5 countries with 28 delivery centers
  • Client base: 105 active client groups, added 28 client groups in H1 FY27
  • Revenue by vertical: Payer ₹18,262 million (89.9%), Provider ₹2,059 million (10.1%) in Q2 FY27

Management Commentary

Ramesh Gopalan, MD and Group CEO, stated: "Our performance in the first half of FY27 reflects broad-based momentum across the business. Our pipeline is healthy with larger deals and a growing set of opportunities with Blues and mid-market plans."

Srinivas Mattapalli, Group CFO, added: "Q2 FY27 was a strong quarter with healthy growth, robust cash generation and our highest adjusted EBITDA margin in six quarters."

Key Performance Indicators (Press Release)

  • Q2 FY27 constant currency growth: 12.2% YoY
  • Adjusted EBITDA: ₹5,353 million (26.3% margin)
  • Adjusted PAT: ₹3,254 million (16.0% margin)
  • Annualized contract value secured: $40.2 million from 31 existing clients and 1 new logo
  • Voluntary attrition rate: 25.7% in Q2 FY27